| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |